Researchers develop a COVID-19 antibody test that doesn’t require a blood sample
- EB Virus Could Be Infected by Kiss: A Hidden Threat Linked to Cancer
- The Silent Threat: How Gas Stoves Pollute Our Homes and Impact Health
- Paternal Microbiome Perturbations Impact Offspring Fitness
- New Report Casts Doubt on Maradona’s Cause of Death and Rocks Manslaughter Case
- Chinese academician unable to provide the exact source of liver transplants
- Early Biomarker for Multiple Sclerosis Development Identified Years in Advance
Researchers develop a COVID-19 antibody test that doesn’t require a blood sample
- AstraZeneca Admits for the First Time that its COVID Vaccine Has Blood Clot Side Effects
- Was COVID virus leaked from the Chinese WIV lab?
- HIV Cure Research: New Study Links Viral DNA Levels to Spontaneous Control
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
Researchers develop a COVID-19 antibody test that doesn’t require a blood sample
Scientists have developed a new minimally invasive, antibody-based test for SARS-CoV-2 that could lead to blood-free testing for many diseases.
The global COVID-19 pandemic is not over, despite the significant and astonishing advances in vaccine technology right now.
A key challenge in limiting the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the rapid and accurate identification of infected individuals.
Now, researchers from Japan have developed a new antibody-based technique that can be used to rapidly and reliably detect SARS-CoV-2 without the need for a blood sample.
The global response to the COVID-19 pandemic has been severely limited by the inability to effectively identify individuals infected with SARS-CoV-2, exacerbated by the high rate of asymptomatic infections (16%-38%).
Until now, the most predominant method of testing has been to collect samples by swabbing the nose and throat.
However, the application of this method is limited by its long detection time (4-6 hours), high cost, and requirement for specialized equipment and medical personnel, especially in resource-limited countries.
An alternative and complementary method for confirming COVID-19 infection involves the detection of SARS-CoV-2-specific antibodies.
Gold nanoparticle-based test strips are now widely used for point-of-care testing in many countries.
They produce sensitive and reliable results in as little as 10-20 minutes, but they require blood samples to be collected by pricking a finger with a puncture device — which can be painful and increase the risk of infection or cross-contamination.
In addition, the kit components used are also potentially biohazardous.
To develop a minimally invasive detection method that avoids these drawbacks, they explored sampling and the interstitial interstitium (ISF) located in the epidermis and dermis of human skin, said lead author Leilei Bao from the Institute of Industrial Science, The University of Tokyo. Test ideas. Bao pointed out that although the antibody level in ISF is about 15%-25% of the antibody level in blood, IgM/IgG antibodies against SARS-CoV-2 can still be detected, and ISF can directly replace blood sampling, which is feasible.
After demonstrating that ISF could be adapted for antibody detection, the researchers developed an innovative method to sample and test ISF.
Beomjoon Kim, the first author of the paper on the study, explains: “First, we developed biodegradable porous microneedles made of polylactic acid that draw ISF from human skin.
Then, we constructed a paper-based An immunoassay biosensor for the detection of SARS-CoV-2-specific antibodies.” By integrating these two elements, the researchers created a compact patch that enables on-site detection of antibodies within 3 minutes (in vitro tested result).
This novel test device has great potential for rapid screening for COVID-19 and many other infectious diseases, which is safe and acceptable to patients. It promises to be used in many countries, regardless of their wealth, and is a key goal of managing infectious diseases globally.
Researchers develop a COVID-19 antibody test that doesn’t require a blood sample
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.